Professional Documents
Culture Documents
WHO EURO 2021 2741 42499 59030 Eng
WHO EURO 2021 2741 42499 59030 Eng
Some rights reserved. This work is available under the Creative Commons Attribution-NonCommercial-ShareAlike 3.0 IGO
licence (CC BY-NC-SA 3.0 IGO; https://creativecommons.org/licenses/by-nc-sa/3.0/igo).
Under the terms of this licence, you may copy, redistribute and adapt the work for non-commercial purposes, provided
the work is appropriately cited, as indicated below. In any use of this work, there should be no suggestion that WHO
endorses any specific organization, products or services. The use of the WHO logo is not permitted. If you adapt the work,
then you must license your work under the same or equivalent Creative Commons licence. If you create a translation of
this work, you should add the following disclaimer along with the suggested citation: “This translation was not created
by the World Health Organization (WHO). WHO is not responsible for the content or accuracy of this translation. The
original English edition shall be the binding and authentic edition: Laboratory licensing. An essential part of the national
laboratory regulatory framework. Copenhagen: WHO Regional Office for Europe; 2021”.
Any mediation relating to disputes arising under the licence shall be conducted in accordance with the mediation rules of
the World Intellectual Property Organization. (http://www.wipo.int/amc/en/mediation/rules/)
Suggested citation. Laboratory licensing. An essential part of the national laboratory regulatory framework. Copenhagen:
WHO Regional Office for Europe; 2021. Licence: CC BY-NC-SA 3.0 IGO.
Sales, rights and licensing. To purchase WHO publications, see http://apps.who.int/bookorders. To submit requests for
commercial use and queries on rights and licensing, see http://www.who.int/about/licensing.
Third-party materials. If you wish to reuse material from this work that is attributed to a third party, such as tables,
figures or images, it is your responsibility to determine whether permission is needed for that reuse and to obtain
permission from the copyright holder. The risk of claims resulting from infringement of any third-party-owned component
in the work rests solely with the user.
General disclaimers. The designations employed and the presentation of the material in this publication do not imply
the expression of any opinion whatsoever on the part of WHO concerning the legal status of any country, territory, city or
area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted and dashed lines on maps
represent approximate border lines for which there may not yet be full agreement.
The mention of specific companies or of certain manufacturers’ products does not imply that they are endorsed or
recommended by WHO in preference to others of a similar nature that are not mentioned. Errors and omissions excepted,
the names of proprietary products are distinguished by initial capital letters.
All reasonable precautions have been taken by WHO to verify the information contained in this publication. However, the
published material is being distributed without warranty of any kind, either expressed or implied. The responsibility for
the interpretation and use of the material lies with the reader. In no event shall WHO be liable for damages arising from its
use.
Joanna Salvi Le Garrec Zwetyenga, Better Labs for Better Health, Infectious Hazards
Management, Health Emergencies program, WHO Regional Office for Europe
Matlyuba Berdieva, Dilshod Davlatov, Munira Karimova, Sherali Rabiyev, Abdulakhad Safarov,
Tamano Safarova, Suhrob Vohidov, Tatyana Volkova
CONTENTS
AKNOWLEDGEMENTS iv
INTRODUCTION 1
AREAS OF ACTIVITIES 1
SCOPE AND PURPOSE OF “ESTABLISHING HEALTH LABORATORY LICENSING” 3
TARGET AUDIENCE 4
METHODOLOGY 5
WHY IS LICENSING NECESSARY AND WHAT CAN LICENSURE OF HEALTH
LABORATORIES PROVIDE? 6
v
Page 0 6
INTRODUCTION
AREAS OF ACTIVITIES
To help countries achieve much needed reforms of their public health
laboratory services, Better Labs for Better Health’s collaborative
activities with Member States and partners focus on four areas:
AREA 1:
Development of national laboratory policies and strategic plans.
AREA 2:
Improvement of national training programmes and implementation
of laboratory quality management systems.
AREA 3:
Establishment of networks for emergency preparedness and
response.
AREA 4:
Advocacy, partnership and leadership.
1
LABORATORY LICENSING
INTRODUCTION
Five Member States – Kyrgyzstan, the Republic of Moldova, Tajikistan, Turkmenistan and
Uzbekistan – had formally committed to the Better Labs for Better Health initiative by 2015.
The first step was to support them in the development of their national laboratory policies
and strategic plans by establishing formally recognized national laboratory working groups
(4).
One of the key gaps identified through this process was the need to
revise the governance and regulatory policies pertaining to health
laboratories.
Review of the relevant legislation should therefore be included in strategic or national public
health programs to ensure development and implementation of laboratory regulations, as
well as the allocation of the necessary funding from the national budget.
Laboratory licensing mechanisms and how licensing is applied vary from country to country.
Laboratory staff, especially managers, should be familiar with the principal provisions and
concepts of the most important laws and regulations that affect laboratories across their
country.
1 Zwetyenga J., Oskam L., Slobodskaya O., Berdieva M., Turkmenova E., Kasymbekova K., Cojocaru R., Costic N., Alieva
L., Djemileva S., Li L., Brown C. S. Better Labs for Better Health: intersectoral challenges and solutions for laboratory systems
strengthening. World Health Organization. Regional Office for Europe. Public Health Panorama; 2015; 1(2): 162–167 (https://
apps.who.int/iris/bitstream/handle/10665/325518/php-1-2-162-167-eng.pdf?sequence=1&isAllowed=y , accessed 30 April
2020).
2
LABORATORY LICENSING
INTRODUCTION
This document aims to provide support and offer guidance to national health authorities
and national health laboratory focal points in their efforts to strengthen laboratory systems.
It defines the regulatory requirements for registration, licensing, certification and/or
accreditation of health laboratories, and applies to all health laboratories (public, private
not-for-profit and private-for-profit). It explains the difference between certification and
accreditation, and details how these can be used throughout the licensing process to
implement quality requirements.
“Establishing licensing” also aims to help countries fulfil the IHR monitoring and evaluation
framework (5) concerning laboratory licensing and the control of laboratory quality, including
strengthening national compliance, specifically with regard to core capacity requirements to
detect, assess, notify and report events in accordance with the IHR (as specified in Articles 5,
6, 7, 10 and 13) (1).
Article 3, Section 4 of the IHR specifies that Member States have the sovereign right to legislate
and to implement legislation in pursuance of their health policies but should uphold the
purpose of the IHR when doing so.
“Establishing licensing” can also be used to identify what can be included in national legislation
concerning licensing.
3
LABORATORY LICENSING
INTRODUCTION
TARGET AUDIENCE
The target audience includes personnel responsible for developing
the licensing legislation in the Ministry of Health or other
responsible authorities.
4
LABORATORY LICENSING
INTRODUCTION
METHODOLOGY
This guidance document is based on a review and analysis of licensing legislation pertaining
to health laboratories from 17 countries.
The approach taken allows comparison of legal requirements in these countries and observes
different models of certification and accreditation, as well as comparing the countries’
approaches to regulating license requirements for tests, facilities, equipment, quality control,
biosafety, etc.
It refers to the WHO “Laboratory biosafety manual” (6), which will be soon replaced by its
fourth edition, WHO “European guidance on standards for infectious diseases laboratories”
(7), and the WHO “Laboratory quality management system” handbook (8). More specific
references applicable to each key element of “Establishing licensing” are provided in relevant
sections of the document.
This subdivision was chosen because it represents the common legal structure of any
legislation and can therefore help foster the implementation and enforcement of the health
laboratory licensing legislation.
5
LABORATORY LICENSING
INTRODUCTION
Ä national policy,
Ä strategic planning for laboratory services,
Ä sufficient and sustainable funding,
Ä training of laboratory staff,
Ä laboratory infrastructure (old and inadequately serviced equipment, a lack of
essential reagents and consumables),
Ä biosafety and biosecurity management,
Ä quality management systems,
Ä quality assurance and quality control protocols.
Many of these key issues can be adequately addressed with the implementation and
enforcement of an elaborated and comprehensive licensing legislation.
Licensure provides the legal basis on which many aspects of laboratory operation can
be sufficiently regulated. It is therefore a valuable legal initiative for health authorities in
streamlining and uniting different laws into one licensing act. Such licensing legislation
also provides the head of a laboratory with a comprehensive and useful overview of legal
requirements to operate a laboratory and provide laboratory services.
6
LABORATORY LICENSING
INTRODUCTION
7
8
1. STRUCTURE OF THE LICENSING
LEGISLATION
The health laboratory licensing legislation should cover procedural law and substantive law.
This objective can be reached by either listing and defining all elements/requirements of the
substantive law in the licensing legislation or referring to the applicable laws (e.g. to labour
laws or safety laws). The procedural law part is in every respect necessary for establishing
health laboratory licensing.
9
LABORATORY LICENSING
1. STRUCTURE OF THE LICENSING LEGISLATION
The general licensing act determines the rules for issuance, renewal and withdrawal of any
license. A related act describes the requirements for licenses for medical activities, mostly
accompanied by a document determining the required standards. In contrast to the stand-
alone licensing act, this approach utilizes general guidelines for any medical activity or health
facility. This means that it is often challenging for health laboratories to ascertain which laws
apply and which standards to implement. To solve this problem, governments or laboratory
associations establish guidelines or lists of minimum criteria. Although these documents are
in some cases not legally binding, they provide a good basis for self-assessment.
This approach is used in, among other countries, Armenia, United Arab Emirates (Abu Dhabi),
Kyrgyzstan, the Russian Federation, Ukraine and the United States of America.
10
LABORATORY LICENSING
1. STRUCTURE OF THE LICENSING LEGISLATION
The health insurance company uses standard contract forms that describe the requirements
and standards for operation of the laboratory. These requirements can be stricter than
requirements stipulated in legislation. In order to receive reimbursement, the service provider
must comply with the terms of the contract. These could include mandatory participation in
an accreditation program.
This approach is used in, among other countries, Austria, Germany, Luxembourg, Switzerland,
and the United Kingdom.
11
12
2. SUBSTANTIVE LAW CONSIDERATIONS
13
LABORATORY LICENSING
2. SUBSTANTIVE LAW CONSIDERATIONS
Some examples of best practice in procurement can be found in the WHO “Manual for
procurement of diagnostics and related laboratory items and equipment” (11).
14
LABORATORY LICENSING
2. SUBSTANTIVE LAW CONSIDERATIONS
Personnel
Legislation should reflect requirements for laboratory personnel and specify their
qualifications. An important step in this regard is aligning the standard staff positions and
qualifications with international standards.
Any revision of the corresponding qualifications should be performed jointly by the national
laboratory community and the health authority.
15
LABORATORY LICENSING
2. SUBSTANTIVE LAW CONSIDERATIONS
Ä all rules and procedures related to data management, reporting and aggregation
are in line with Article 45 of IHR and national legislation for notifying WHO about
emergencies;
Ä information on test results can be exchanged vertically and horizontally within the
laboratory services structure and with third-party authorities and organizations in
emergencies;
Ä a legal basis is prepared for the transition of laboratories from paper-based
information management to the use of electronic LIMS, including data reporting and
sharing (13).
Since the HIS is often regulated in many separate laws, it is more useful to make references
in the licensing legislation to the applicable laws. Nevertheless, the inspection for the correct
implementation and maintenance of an adequate LIMS might be led or supervised by the
licensing authority. Therefore, the licensing law should give the mandate for inspecting the
LIMS to the licensing authority and refer to the applicable health information legislation.
16
LABORATORY LICENSING
2. SUBSTANTIVE LAW CONSIDERATIONS
The licensing legislation should mandate quality management, and link certification/
accreditation requirements and participation in EQA programmes to the licensing process.
If certification or accreditation is not a requirement for the licensing, it is essential that the
licensing legislation defines at least the minimal criteria for an adequate QMS. A suitable
framework for these minimal criteria is the usage of the 12 quality system essentials (QSEs).
These QSEs were adapted from the Clinical and Laboratory Standards Institute’s (CLSI)
guideline for implementing quality management in clinical laboratories GP26-A3.2 (14); now
revised and published under the name “A quality management system model for laboratory
services” (15). How these QSEs should be implemented can be found in the WHO handbook
“Laboratory quality management system” (8).
1. Organization
2. Personnel
3. Equipment
4. Purchasing and inventory
5. Process control
6. Information management
7. Documents and records
8. Occurrence Management
9. Assessment
10. Process improvement
11. Customer service
12. Facilities and safety.
17
LABORATORY LICENSING
2. SUBSTANTIVE LAW CONSIDERATIONS
Accreditation is used in regulated sectors and voluntarily in other areas and increases trust in
conformity assessment – also internationally. An accreditation certificate demonstrates the
technical capacity of an organization and therefore the fact that it complies with the adopted
standards.
Different models can be used to control the quality of laboratories through certification and/
or accreditation:
Voluntary accreditation against international laboratory standards (e.g. Finland, Ireland,
Netherlands, most developing countries). Laboratories that wish to obtain an international
recognition of quality may decide to get accredited against an international standard, but this
process is not required by law.
Mandatory accreditation against international laboratory standards (e.g. Australia, Canada,
Dubai, France). All laboratories are obliged to obtain the specified accreditation. In this
approach there may be a need for a transition period for the laboratories to prepare to meet
the international standards.
A mixed model: certain laboratories are subject to mandatory accreditation against
international laboratory standards (e.g. reference and centralized laboratories, etc.), whereas
accreditation is voluntary for other laboratories. These other laboratories typically must
comply with national laboratory standards to obtain certification (e.g. Belgium, Thailand, some
states in the United States of America).
WHO recommends that countries with limited resources should have national laboratory
standards as a minimum requirement, while national reference laboratories are encouraged
to aim at meeting international standards such as ISO 15189 (17, 18). A minimum set of
requirements/standards for laboratories seeking to implement QMS can be found in the WHO
“European guidance on standards for infectious diseases laboratories” (7).
The choice of the approach remains the country’s decision and whatever approach is chosen,
it should be integrated into the licensing process.
18
LABORATORY LICENSING
2. SUBSTANTIVE LAW CONSIDERATIONS
Accreditation bodies around the world, which have been evaluated by peers as competent,
have signed an arrangement that enhances the acceptance of products and services across
national borders. The purpose of this arrangement, the ILAC MRA, is to create an international
framework to support international trade.
Each accreditation body that is a signatory to the ILAC MRA commits to (23):
maintain conformity with the current version of ISO/IEC 17011 “Conformity assessment –
Requirements for accreditation bodies accrediting conformity assessment bodies”;
ensure that all laboratories and inspection bodies that are accredited comply with appropriate
laboratory and inspection bodies standards (currently ISO/IEC 17025 “General requirements
for the competence of testing and calibration laboratories”, ISO 15189 “Medical laboratories
– Requirements for quality and competence”, and ISO/IEC 17020 “Conformity assessment –
Requirements for the operation of various types of bodies performing inspection”).
19
LABORATORY LICENSING
2. SUBSTANTIVE LAW CONSIDERATIONS
There are two options for integrating laboratory standards into the licensing process:
include references to the applicable laboratory standards (e.g. guidelines from an independent
community, minimal criteria list from the health authority, mandatory accreditation against
ISO 15189) in the licensing legislation;
set out the laboratory standards in the licensing legislation and include them as licensing
requirements. In contrast to the first option, the political decision-makers and the legislator
integrate the standards into national legislation.
Countries that have implemented mandatory certification/accreditation have had at least the
following three elements in place:
a policy framework that makes certification or accreditation a requirement for laboratories,
defined quality standards against which laboratories can be assessed,
conformity assessment bodies authorized to assess laboratories and their performance against
the designated quality standards.
20
LABORATORY LICENSING
2. SUBSTANTIVE LAW CONSIDERATIONS
International standards
International standards have been developed to allow international recognition of quality,
such as the standards from the International Organization for Standardization (ISO), the
International Society for Quality in Health Care (25), the Joint Commission International (26)
and the CLSI, formerly the National Committee on Clinical Laboratory Standards.
ISO published these documents relating to the accreditation process of health laboratories:
ISO 15189:2012 “Medical laboratories -- Requirements for quality and competence” (12),
ISO/IEC 17025:2017 “General requirements for the competence of testing and calibration
laboratories” (20).
The CLSI published the following documents that are relevant to QMS in medical laboratories:
HS1-A2 “A quality management system model for health care”, 3rd ed. (27),
QMS01 “A quality management system model for laboratory services”, 5th ed. (15).
National standards
National standards have been developed by some countries to be closer to the needs of
laboratories within the country. These standards are used as regulatory standards to introduce
quality management in laboratories and are largely based on international standards.
Certification standards
The ISO 9001:2015 “Quality management systems – Requirements” (28) is used by organizations
to demonstrate their ability to consistently provide products and services that meet customer
and management requirements and to demonstrate continuous improvement, while the
ISO 15189 and ISO 17025 focus in addition on technical requirements (being competent in
providing reliable results).
21
LABORATORY LICENSING
2. SUBSTANTIVE LAW CONSIDERATIONS
22
LABORATORY LICENSING
2. SUBSTANTIVE LAW CONSIDERATIONS
23
LABORATORY LICENSING
2. SUBSTANTIVE LAW CONSIDERATIONS
The licensing legislation should stipulate that if premises are renovated or modernized in a
way that might impact the safety of operations, the license must be renewed (see sub-section
License Renewal in Section 3.3.3).
24
LABORATORY LICENSING
2. SUBSTANTIVE LAW CONSIDERATIONS
Optional:
25
26
3. PROCEDURAL LAW CONSIDERATIONS
Whichever authorities have been designated, the legislation should stipulate the following:
The licensing authority should have the right to carry out scheduled and unscheduled
inspections of licensed laboratories. Random inspections should be allowed on reasonable
grounds, such as patients’ complaints, incidents in the laboratory, failure under EQA schemes,
etc.
It should be mandatory to implement recommendations deriving from assessment visits. If not
implemented, measures such as temporary suspension of operations and license revocation
should be stipulated.
27
LABORATORY LICENSING
3. PROCEDURAL LAW CONSIDERATIONS
However, such control mechanisms should correlate to and be in line with legislation promoting
the removal of administrative barriers for business and the prevention of corruption. For
instance, online application for the license could help to reduce the length of the license
application process and make it more transparent.
The legislation should give the licensing authority the right to grant, refuse, temporarily
suspend or ‘revoke a license, and to impose appropriate penalties. Decisions to grant or refuse
to grant the license shall be bound to the reasons stated in the licensing legislation or in the
respective regulations.
The licensing authority should be required to publish regulations on the standards and
requirements for obtaining a health laboratory license.
The legislation should give the licensing authority the right to inspect and control compliance
of the health laboratories with the requirements and standards stipulated in the licensing
legislation. The inspection and control can be assigned to a body or an authority. In this
case the licensing authority has to supervise the assigned body or authority. The duties and
competences of the inspectors must be defined in the licensing legislation, as well as how an
onsite inspection has to be conducted.
Likewise, the licensing authority should have the power to demand an initial registration and
application request from all the existing health laboratories within a specified period (e.g. 6
weeks), following the enforcement of the licensing legislation.
The licensing authority should maintain and publish a list of all registered and licensed health
laboratories.
28
LABORATORY LICENSING
3. PROCEDURAL LAW CONSIDERATIONS
In the general license application process, licensing authorities can review the list of performed
tests as a separate document within the license application package.
In the case where licensing legislation specifies the tests laboratories must perform in order
to be licensed, it is recommended that the list of laboratory tests should not to be limited to
specific activities only but should also include a category named “other activities” or “other
tests” (these are called an open list). The open list allows any additional test to be listed in the
application and be legitimately covered by the licensing legislation, which avoids amendments
to the licensing legislation whenever new types of tests and more advanced technologies need
to be implemented.
29
LABORATORY LICENSING
3. PROCEDURAL LAW CONSIDERATIONS
Application in some countries is limited to one step, and registration is done when the
application is being processed.
The status (name, ownership, location and head of the laboratory) of all health laboratories
(government-owned and private) is requested and documented in a register. In some countries
the modus for applying is paper-based, in others it can be paper-based or online, and in some
countries only online application is possible.
The registration document is only valid for a specified period. The management of the
laboratory must apply for the license (sometimes called a permanent license or license to
operate) during this period. Upon request, the period can be prolonged by the licensing
authority.
The initial registration and review of the legal requirements for the health laboratory can have
two different implications:
It provides a legal basis for the laboratory to establish its service. The registration does not
authorize providing service to clients.
It provides the legal basis to establish the laboratory and provide service to clients. This
option is used when accreditation or certification is mandatory for obtaining a license. Since
accreditation can only be properly evaluated in daily operations, the laboratory has to provide
service to clients prior to the license application. The legal requirements for registration in this
scenario are stricter and often accompanied by an onsite inspection.
30
LABORATORY LICENSING
3. PROCEDURAL LAW CONSIDERATIONS
Successful registration does not oblige the licensing authority to license the health laboratory.
Licensing legislation can specify registration fees for registration and these fees can include
onsite inspection.
The application for the registration should be accompanied by the registration form and all
documents required by the licensing legislation. If particular documents lack information or
provide insufficient information, the licensing authority should specify a period within which
the applicant must submit the necessary information; and if the necessary information is not
submitted on time, the application should be considered withdrawn, and the applicant must
submit a new application. The licensing authority can also ask for further information based
on legal grounds.
Depending on the chosen process, the licensing authority can demand an onsite inspection in
the registration process as a legal requirement. The result of this inspection should be clearly
communicated to both the licensing authority and the management of the laboratory, and
corrective actions should be suggested.
If an application for registration is rejected by the licensing authority, the licensing authority
should provide reasons and, if applicable, offer suggestions for corrective actions.
31
LABORATORY LICENSING
3. PROCEDURAL LAW CONSIDERATIONS
32
LABORATORY LICENSING
3. PROCEDURAL LAW CONSIDERATIONS
The health authority can define and stipulate several grounds for refusal in the licensing
legislation. For instance, the grounds could be (36):
There is no demand for an expansion of the laboratory services (see Section 3.4 Assessing the
need for laboratories).
The applicant is not able to provide the intended laboratory service.
The applicant is not of good character, i.e. has been convicted of an offence involving fraud or
dishonesty, is an undischarged bankrupt (if the applicant is a sole proprietor).
The partners are not of good character, i.e. a partner has been convicted of an offence involving
fraud or dishonesty or is an undischarged bankrupt (if the applicant is a partnership).
The applicant has not implemented adequate and efficient management, and an
administration structure to support the proper conduct of the laboratory service.
The initial registration process for a new health laboratory can provisionally be under the name
of the laboratory owner. Decisions from the licensing authority about the health laboratory’s
registration will be therefore directed to the laboratory owner as a natural person, since
the laboratory cannot be established as a company. Therefore, it is useful to dedicate one
paragraph in the licensing legislation to this issue, so that not only established companies,
but also natural persons can apply for the initial registration. The name of the facility must be
carefully chosen and should not mislead the public in any way regarding the extent and type
of service the health laboratory provides. Once the facility name is chosen, it should not be
permitted to change it without the licensing authority’s prior approval (35).
33
LABORATORY LICENSING
3. PROCEDURAL LAW CONSIDERATIONS
Usually, a license is a special permit for a legal entity or an individual to carry out specific
activities. It is supported by a document issued by the licensing authority on paper or in digital
form.
The license provides the legal basis for the management of the laboratory to operate the
laboratory.
Licensing process
The laboratory should apply to the licensing authority for the license for provision of the
laboratory service after the laboratory is registered with the licensing authority, except the
countries, where registration is not required.
Licensing legislation usually specifies fees for the licensing process. These fees can include
onsite inspection and should be paid during the application process.
The application for the license should be accompanied by the licensing application form,
the registration certificate, if registration is required, and all other documents required by
the licensing legislation. If documents lack information or provide insufficient information,
the licensing authority should specify a period within which the applicant must submit
the necessary information; and if the necessary information is not submitted on time, the
application should be considered withdrawn, and the applicant must submit a new application.
The licensing authority can also ask for further information based on legal grounds.
During the licensing process the licensing authority usually performs or arranges an onsite
inspection. The result of this inspection should be clearly communicated to applicant and
corrective actions should be suggested. If the licensing legislation requires accreditation or
certification, the onsite inspection should be performed by the accreditation or certification
body. The inspection body should be obliged to share any information on the result with the
licensing authority but should not be permitted to give any information to third parties.
If an application for the license is rejected by the licensing authority, the licensing authority
should provide reasons and offer suggestions for corrective actions.
The license should be granted if every requirement is fulfilled and the licensing authority is
satisfied that the operation of the health laboratory will provide a safe, secure and quality-
driven service.
34
LABORATORY LICENSING
3. PROCEDURAL LAW CONSIDERATIONS
35
LABORATORY LICENSING
3. PROCEDURAL LAW CONSIDERATIONS
If a license application is rejected by the licensing authority, a detailed list of issues and, if
applicable, a list of corrective actions should be provided. The license applicant can then
resubmit the application with applicable fees.
There can be several grounds for refusal that the health authority can define and stipulate in
the licensing legislation. The following is an overview of possible considerations:
The applicant has not registered with the licensing authority, if such a registration is required
by legislation.
The applicant is not capable of providing the offered laboratory service.
The applicant has not implemented adequate and efficient management and an
administration structure to support the proper conduct of the laboratory service.
The applicant does not fulfil all requirements stipulated in the licensing legislation.
36
LABORATORY LICENSING
3. PROCEDURAL LAW CONSIDERATIONS
License renewal
The license renewal process is used in two different scenarios:
when the laboratory is obliged to renew its license due to the expiration of the license’s validity
period;
whenever there is a change that has a lasting effect on the operation of the laboratory (e.g.
planning to build additional laboratory capacity, offering different tests, etc.).
Compared to a new application, the renewal process should take less time and the application
fees should be lower. If an onsite inspection is needed, additional fees can be charged. The
application process should be clearly described in the licensing legislation and preferably
accompanied by a short explanatory document for the laboratory owners.
If the requirements for the renewal of a license are fulfilled, the licensing authority should renew
the license for the period specified in the licensing legislation (e.g. one or two years). In some
instances (e.g. voluntarily participation in an accreditation process of the health laboratory)
to be defined by the licensing authority, the legislation could allow for prolongation of the
license validity period without going through the full license renewal process.
37
LABORATORY LICENSING
3. PROCEDURAL LAW CONSIDERATIONS
License expiration
The licensee’s failure to file an application for the renewal of the license within the specified
time should result in the expiration of the current license upon the license’s last effective date.
Continued operation after expiration of the license should result in financial penalties and in
prosecution as a legal offence.
38
LABORATORY LICENSING
3. PROCEDURAL LAW CONSIDERATIONS
The licensing legislation should also regulate reinspection, including how the fees should be
paid and in what periods. Licensing legislation can in some cases allow for an increase (e.g.
capped in the legislation at 20 percent maximum) of the prescribed fee, if the administrative
process is more complicated than normal (e.g. the license applicant forgets to send the right
documents or sends documents with errors), or if the process of inspection is only possible
with specific constraints (e.g. license applicant does not prepare the necessary papers for the
inspection or forgets the appointment).
39
LABORATORY LICENSING
3. PROCEDURAL LAW CONSIDERATIONS
Investigative body: legislation in some countries assigns the authorization to evaluate the
need for another laboratory to the head of the health authority (e.g. Canada, France, Malaysia)
or to an independent agency (e.g. Austria – Gesundheit Österreich GmbH).
The assessment criteria can be included in the licensing legislation or the legislation can
mandate an authority to establish such criteria. This list should provide a comprehensive
overview, but is not limited to the below mentioned criteria:
number of existing facilities and provided tests (e.g. can be exceeded max. 25-50% higher as
suggested in the national health plan),
location of the new laboratory (including the distance between related laboratories),
class and specialty of proposed tests,
number of samples collected, transported and referred,
cost of providing and developing additional testing,
the effect on the quality of patient care and access to care, etc.
As certain aspects of the assessment are not necessarily based on hard facts, it is an advantage
to authorize an independent body to perform the assessment. This independent body can
assess the need from an objective point of view, while being guided by the objectives from the
health authority’s national health plan.
40
4. FURTHER ASPECTS FOR
CONSIDERATION
41
TERMS AND ABBREVIATIONS
TERMS
Procedure by which an authoritative body gives formal recognition that an organization is competent
Accreditation to carry out specific tasks (37).
An organization or agency with the authorized right and authority to inspect a facility (e.g. laboratory)
Accreditation
and provide written evidence of its compliance (certification) and competence (accreditation) with a
(and
standard (8). According to the ISO definition, the accreditation body is an accredited organization or
certification) agency and the certification body is an organization or agency with an authorized right and authority
body that can choose whether or not to be accredited (37).
Laboratory biosafety describes the containment principles, technologies and practices that are
Biosafety implemented to prevent the unintentional exposure to biological agents and toxins, or their accidental
release (30).
Laboratory biosecurity describes the protection, control and accountability for valuable biological
Biosecurity materials within laboratories, in order to prevent their loss, theft, misuse, diversion, unauthorized
access, or intentional release, whether or not the bio risk(s) is acceptable (30).
The provision by an independent body of a written assurance (a certificate) that the product, service or
Certification system (e.g. laboratory) in question meets s pecific standards (37).
A body that performs conformity assessment activities including calibration, testing, certification and
inspection (38).
Conformity Note: conformity assessment activities performed by conformity assessment bodies include, but
assessment body are not limited to, testing, calibration, inspection, certification of management systems, persons,
products, processes and services, provision of proficiency testing, production of reference materials,
validation and verification.
Head of the The legal representative of the laboratory, usually the owner or medical director of a health laboratory.
laboratory Can be different from the license applicant or the licensee.
Any specialized facility that performs laboratory testing on specimens to provide information for
achieving defined health-related purposes, such as medical diagnostics, disease surveillance, food
Health
quality control and research (8). For the purpose of this document, a more general definition of “health
laboratory laboratories” is used to include other laboratories performing functions related to the health sector.
These include government-owned, public health laboratories and private medical laboratories.
A special permit to carry out specific activities as a legal entity or an individual that is supported by a
License document issued by the licensing authority on paper or in digital form.
License
A legal entity or an individual applying to the licensing body for a license.
applicant
42
The activity of licensing bodies for granting and renewing (if a limited license validity period is
Licensing stipulated by law) a license, the implementation of licensing control mechanisms, suspension,
termination and revocation of licenses, formation and maintenance of the register of licenses.
Licensing
A public organization authorized by law and, if applicable, its territorial branches engaged in licensing.
authority
The granting of ability to practice, usually provided by a national agency. Licensure is usually based on
Licensure demonstrated knowledge, training and skills. Generally, when laboratory licensure is used, it is a legal
requirement for operation (8).
Minimum set of A list of defined criteria governing the operation of a health laboratory. This list constitutes the
requirements minimum acceptable state of the laboratory operation.
Mutual
An agreement signed by the signatory accreditation bodies to recognise the equivalence of the
recognition accreditation programs operated within the scope of their signatory status (39).
arrangement
Procedural law Legal rules that govern the process for determining the rights and obligations of involved parties (40).
Requirements for the regulation of processes are recorded in documents called “standards”. National
Standards and international quality standards are developed and maintained by several organizations (12).
Substantive law Legal rules that determine the rights and obligations of individuals and collective bodies (40).
ABBREVIATIONS
CLIA Clinical laboratory improvement LIMS Laboratory information
amendments management system
CLSI Clinical and Laboratory Standards MRA Mutual recognition
Institute arrangement
EQA External quality assessment QMS Quality management system
HIS Health information system QSE Quality system essential
IHR International Health Regulations SOP Standard operating
(2005) procedure
ILAC International Laboratory WHO World Health Organization
Accreditation Cooperation
ISO International Organization for
Standardization
43
REFERENCES
2. Health 2020: A European policy framework and strategy for the 21st century. Geneva: World Health
Organization; 2013 (http://www.euro.who.int/__data/assets/pdf_file/0011/199532/Health2020-
Long.pdf?ua=1, accessed 30 April 2020).
3. Better Labs for Better Health [website]. Copenhagen: World Health Organization, Regional Office
for Europe (http://www.euro.who.int/en/health-topics/Health-systems/laboratory-services/better-
labs-for-better-health, accessed 30 April 2020).
4. Zwetyenga J., Oskam L., Slobodskaya O., Berdieva M., Turkmenova E., Kasymbekova K., Cojocaru
R., Costic N., Alieva L., Djemileva S., Li L., Brown C. S. Better Labs for Better Health: intersectoral
challenges and solutions for laboratory systems strengthening. World Health Organization.
Regional Office for Europe. Public Health Panorama; 2015; 1(2): 162–167 (https://apps.who.int/iris/
bitstream/handle/10665/325518/php-1-2-162-167-eng.pdf?sequence=1&isAllowed=y, accessed 30
April 2020).
5. Joint external evaluation tool: International Health Regulations (2005). 2nd ed. Geneva: World
Health Organization; 2018 (https://www.who.int/ihr/publications/WHO_HSE_GCR_2018_2/en/,
accessed 30 April 2020).
6. Laboratory biosafety manual. 3rd ed. Geneva: World Health Organization; 2004 (http://www.who.
int/csr/resources/publications/biosafety/Biosafety7.pdf, accessed 30 April 2020).
7. WHO European guidance on standards for infectious diseases laboratories. Copenhagen: World
Health Organization, Regional Office for Europe; 2012 (http://www.euro.who.int/__data/assets/
pdf_file/0005/133457/e94772v2.pdf, accessed 30 April 2020).
8. Laboratory quality management system handbook. Geneva: World Health Organization; 2011
(http://apps.who.int/iris/bitstream/handle/10665/44665/9789241548274_eng.pdf?sequence=1,
accessed 30 April 2020).
9. Petit E., Tasse A. M., Godard B. An empirical analysis of the legal frameworks governing genetic
services labs in Canadian provinces. Health Law Review; 2008; 16(3): 65–72.
10. Malone B. A new era for lab reimbursement. Clinical Laboratory News; 2014 (https://www.aacc.org/
publications/cln/articles/2014/june/lab-reimbursement.aspx, accessed 30 April 2020).
44
REFERENCES
11. Manual for procurement of diagnostics and related laboratory items and equipment.
Geneva: World Health Organization; 2013 (https://www.who.int/diagnostics_laboratory/
publications/130627_manual_for_procurement_of_diagnostics-001-june2013.pdf, accessed 30
April 2020).
12. ISO 15189:2012 Medical laboratories – requirements for quality and competence. Geneva:
International Organization for Standardization; 2012 (https://www.iso.org/standard/56115.html,
accessed 30 April 2020).
13. Yusof M. M., Arifin A. Towards an evaluation framework for laboratory information systems. J
Infect Public Health; 2016; 9(6): 766–773 (https://www.sciencedirect.com/science/article/pii/
S1876034116301344, accessed 30 April 2020).
14. Application of a quality management system model for laboratory services; approved guideline.
3rd ed. GP26-A3. Wayne (PA): CLSI/NCCLS; 2004.
15. A quality management system model for laboratory services. CLSI guideline QMS01, 5th ed. Wayne
(PA): Clinical Laboratories and Standards Institute; 2019.
16. Datema T. A., Oskam L., Klatser P. R. Review and comparison of quality standards, guidelines and
regulations for laboratories. Afr J Lab Med; 2012; 1(1): 3 (https://www.ncbi.nlm.nih.gov/pmc/
articles/PMC5644525/, accessed 30 April 2020).
17. Joint WHO-CDC conference on health laboratory quality systems. 9–11 April 2008, Lyon, France.
Meeting report. Geneva: World Health Organization; 2008 (https://www.who.int/csr/ihr/lyon/
report20080409.pdf?ua=1, accessed 30 April 2020).
18. Alemnji G., Edghill L., Guevara G., Wallace-Sankarsingh S., Albalak R., Cognat S., Nkengasong
J., Gabastou J.-M. Development and implementation of the Caribbean laboratory quality
management systems stepwise improvement process (LQMS-SIP) towards accreditation. Afr J Lab
Med; 2017; 6(1): 496 (https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5523911/, accessed 30 April
2020).
19. ISO/IEC 17011:2017 Conformity assessment – Requirements for accreditation bodies accrediting
conformity assessment bodies. Geneva: International Organization for Standardization; 2017
(https://www.iso.org/standard/67198.html, accessed 30 April 2020).
20. ISO/IEC 17025:2017 General requirements for the competence of testing and calibration
laboratories. Geneva: International Organization for Standardization; 2017 (https://www.iso.org/
standard/66912.html, accessed 5 May 2020).
45
REFERENCES
21. ISO/IEC 17020:2012 Conformity assessment -- Requirements for the operation of various types
of bodies performing inspection. Geneva: International Organization for Standardization; 2012
(https://www.iso.org/standard/52994.html, accessed 4 May 2020).
24. International Society for Quality in Health Care [website]. (https://www.isqua.org/, accessed 30
April 2020).
26. A quality management system model for health care. 3rd ed. HS1-A2. Wayne (PA): Clinical
Laboratories and Standards Institute; 2004.
27. ISO 9001:2015 Quality management systems – Requirements. Geneva: International Organization
for Standardization; 2015 (https://www.iso.org/standard/62085.html, accessed 1 May 2020).
28. Recommendations on the transport of dangerous goods. Model Regulations. 21st ed. New York and
Geneva: United Nations; 2019 (https://www.unece.org/trans/danger/publi/unrec/rev20/20files_e.
html, accessed 1 May 2020).
29. Biorisk management. Laboratory biosecurity guidance. Geneva: World Health Organization; 2006
(http://www.who.int/csr/resources/publications/biosafety/WHO_CDS_EPR_2006_6.pdf, accessed 1
May 2020).
30. Safety in health-care laboratories. Geneva: World Health Organization; 1997 (http://apps.who.int/
iris/bitstream/10665/63993/1/WHO_LAB_97.1.pdf, accessed 4 May 2020).
31. Guidance on regulations for the transport of infectious substances 2019–2020. Geneva: World
Health Organization; 2019 (https://www.who.int/ihr/publications/WHO-WHE-CPI-2019.20/en/,
accessed 1 May 2020).
32. ISO 35001:2019 Biorisk management for laboratories and other related organisations. Geneva:
International Organization for Standardization; 2019 (https://www.iso.org/standard/71293.html,
accessed 1 May 2020).
33. ISO 15190:2020 Medical laboratories – Requirements for safety. Geneva: International Organization
for Standardization; 2020 (https://www.iso.org/standard/72191.html, accessed 1 May 2020).
46
REFERENCES
34. Clinical laboratory regulation. Dubai: Dubai Health Authority; 2012 (https://www.dha.gov.ae/
Documents/Regulations/Clinical%20Laboratory%20Regulation.pdf, accessed 1 May 2020).
35. The Pathology Laboratory Act 674. Parliament of Malaysia, Malaysia; 2007 (http://www.agc.gov.my/
agcportal/uploads/files/Publications/LOM/EN/Act%20674.pdf, accessed 2 May 2020).
37. Regulation (EC) № 765/2008 of the European Parliament and of the Council. Article 2, point 13;
2008.
38. Delivering a safer world. Australia: International Laboratory Accreditation Cooperation; 2018
(https://ilac.org/latest_ilac_news/accreditation-delivering-a-safer-world/, accessed 28 May 2020).
40. Looi L.-M. The pathology laboratory Act 2007 explained. Malays J Pathol; 2008; 30(1): 1–10 (http://
www.mjpath.org.my/2008.1/01_Pathology_Lab_Act.pdf, accessed 2 May 2020).
41. Burnett D., Blair C., Haeney M. R., Jeffcoate S. L., Scott K. W., Williams D. L. Clinical pathology
accreditation: standards for the medical laboratory. J Clin Pathol; 2002; 55(10): 729–733 (https://
www.ncbi.nlm.nih.gov/pmc/articles/PMC1769782/, accessed 1 May 2020).
42. Huntley P. Service specification for pathology/laboratory medicine. Kent and Medway Pathology
Network, United Kingdom National Health Service; 2010 (http://www.pathology.plus.com/docs/
PathServiceSpecKM.pdf, accessed 28 May 2020).
43. Tim H. P. The regulatory landscape for pathology service. England: The Royal College of
Pathologists; 2017 (https://www.rcpath.org/discover-pathology/news/the-regulatory-landscape-
for-pathology-services.html, accessed 1 May 2020).
44. Guidance for providers on meeting the regulations. Care Quality Commission; 2015 (https://www.
cqc.org.uk/files/guidance-providers-meeting-regulations, accessed 1 May 2020).
45. ICAO Technical instructions for the safe transport of dangerous goods by air https://www.icao.int/
safety/DangerousGoods/Pages/technical-instructions.aspx, accessed 1 May 2020).
46. European standard EN 12469:2000 “Performance criteria for microbiological safety cabinets (http://
standards.nsf.org/apps/group_public/download.php/1840/EN%2012469%202000.pdf, accessed 1
May 2020).
47
ANNEX. COUNTRY EXAMPLES
Armenia
Law of Republic of Armenia on licensing, dated May 30, 2001 (https://cis-legislation.com/
document.fwx?rgn=8670, accessed 29 May 2020).
Governmental Resolution of Republic of Armenia on approval the list of activities in the area of
medical care and medical services # 276-N, dated March 27, 2008.
Governmental Resolution of Republic of Armenia on approval of technical and professional
qualification requirements and conditions necessary for medical care and service in polyclinics
(mixed, adults and children), separate specialized cabinets, offices of family physicians,
medical ambulatories, rural health centers, nursing posts, well woman clinics and hospitals
(specialized) # 1936-N, dated December 5, 2002.
Governmental Resolution of Republic of Armenia on approval of the licensing procedures for
drug production, pharmacy business and implementation of medical care and service, as well
as for curricula of medical education in colleges and universities, and the licensing forms of
carrying out the mentioned activities # 867, dated June 29, 2002.
Australia
Website with information for Approved Pathology Authority, Australian Government (https://
ablis.business.gov.au/service/ag/approved-pathology-authority/80, accessed 15 May 2020).
France
Code de la santé publique Article L1421-1 [Public Health Code Article L1421-1] (in French,
https://www.legifrance.gouv./ accessed 29 May 2020).
Code de la santé publique. Partie législative (Articles L1110-
1 à L6441-1). [Public Health Code Article L6441-1] (in French,
TEXT000006072665&idArticle=LEGIARTI000006687045&dateTexte=&categorieLien=cid,
accessed 1 May 2020).
Références juridiques – Biologie médicale [Legal references – Medical biology] (in French,
https://www.ameli.fr/sites/default/files/Documents/5245/document/guide_references_
biologiques_-edition_2019_-_assurance_maladie.pdf, accessed 1 May 2020).
Guide des références juridiques – Biologie médicale [Guide to legal references – Medical
biology] (in French, https://www.ameli.fr/laboratoire-danalyses-medicales/textes-reference/
references-juridiques/guide-references-juridiques-biologie-medicale, accessed 1 May 2020).
Germany
Richtlinie der Bundesärztekammer zur Qualitätssicherung laboratoriumsmedizinischer
Untersuchungen [Guideline of the German Medical Association for quality assurance of
laboratory medical examinations] (in German, https://www.bundesaerztekammer.de/
fileadmin/user_upload/downloads/pdf-Ordner/RL/Rili-BAEK-Laboratoriumsmedizin.pdf,
accessed 2 May 2020).
Gesetz zur Reform der Strukturen der Krankenhausversorgung (Krankenhausstrukturgesetz,
KHSG) [Law to reform the infrastructure of hospital care (Hospital Infrastructure Act)], 2015 (in
German, https://www.bgbl.de/xaver/bgbl/start.xav?startbk=Bundesanzeiger_BGBl&start=//*[@
attr_id=%27bgbl115s2229.pdf%27]#__bgbl__%2F%2F*%5B%40attr_id%3D%27bgbl115s2229.
pdf%27%5D__1590681536390, accessed 28 May 2020).
48
ANNEX. COUNTRY EXAMPLES
§ 135a SGB V Verpflichtung der Leistungserbringer zur Qualitätssicherung [Quality assurance
obligation of the service providers]; (in German, https://www.sozialgesetzbuch-sgb.de/
sgbv/135a.html, accessed 28 May 2020).
Volltexte von deutschen Gesetzen mit Laborbezug [German laws relating to the laboratory];
(in German, https://analytik.news/links/fachliteratur/laborrecht/gesetze.html, accessed 2 May
2020).
Luxemburg
Code de la santé [Health Code] (in French, http://data.legilux.public.lu/file/eli-etat-leg-code-
sante-20161118-fr-pdf.pdf, accessed 2 May 2020).
Malaysia
The pathology laboratory Act 674. Certification. International Organization for Standardization
[website]. ( https://www.iso.org/certification.html , accessed 1 May 2020).
Looi L.-M. The pathology laboratory Act 2007 explained, Huber A. R. Kriterien zum Betreiben
von medizinisch-analytischen Laboratorien (KBMAL). 2.1 ed. Switzerland: Pipette; 2006 (
https://www.sulm.ch/pipette_magazin/files/pipette/2006-04/2006-04-101.PDF , accessed 28
May 2020). .
Malta
Requirements for medical laboratories (https://deputyprimeministercms.gov.mt/en/hcs/
Documents/Medlab%20COL.pdf, accessed 2 May 2020).
Philippines
Department of Health, documents regulating clinical laboratories (https://hfsrb.doh.gov.
ph/?page_id=46, accessed 2 May 2020):
Ö Revised rules and regulations governing the licensure and regulation of
clinical laboratories in the Philippines. 2007 (https://hfsrb.doh.gov.ph/
wp-content/uploads/2019/07/ao2007-0027.pdf, accessed 2 May 2020).
Ö Republic act No. 4688. An act regulating the operation and maintenance of clinical
laboratories and requiring the registration of the same with the department of health,
providing penalty for the violation thereof, and for other purposes, 1966 (https://
www.lawphil.net/statutes/repacts/ra1966/ra_4688_1966.html, accessed 2 May 2020).
Ö Schedule of fees for the licensure of general clinical laboratories and the
registration of special clinical laboratories, 2008 (https://hfsrb.doh.gov.ph/
wp-content/uploads/2019/07/ao2008-0007.pdf, accessed 2 May 2020).
Ö Assessment tool for the licensing for a general clinical laboratory,
2016 (https://hfsrb.doh.gov.ph/wp-content/uploads/2019/07/
rev3clg-lto-at-172016.pdf, accessed 2 May 2020).
Russian Federation
General information about regulatory framework for federal service for surveillance in
healthcare (https://www.roszdravnadzor.ru/en, accessed 2 May 2020).
49
ANNEX. COUNTRY EXAMPLES
Switzerland
Schweizerischen Kommission für Qualitätssicherung im medizinischen Labor [Website of Swiss
Commission for quality assurance in medical laboratories] (in German, http://www.qualab.
swiss/, accessed 2 May 2020).
Huber A. R. Kriterien zum Betreiben von medizinisch-analytischen Laboratorien (KBMAL).
[Criteria for operating medical-analytical laboratories] (in German) (41).
Verordnung über mikrobiologische Laboratorien. Der Schweizerische Bundesrat [Regulation on
microbiological laboratories. The Swiss Federal Council]. 2016 (in German, https://www.admin.
ch/opc/de/classified-compilation/20143116/index.html, accessed 2 May 2020).
Verordnung über die Krankenversicherung. Der Schweizerische Bundesrat [Regulation on
health insurance. The Swiss Federal Council]. 1995 (in German, https://www.admin.ch/opc/de/
classified-compilation/19950219/202001010000/832.102.pdf, accessed 2 May 2020).
50
51
The WHO Regional Office for Europe
Member States:
Albania Lithuania
Andorra Luxembourg
Armenia North Macedonia
Austria Malta
Azerbaijan Monaco
Belarus Montenegro
Belgium Netherlands
Bosnia and Herzegovina Norway
Bulgaria Poland
Croatia Portugal
Cyprus Republic of Moldova
Czechia Romania
Denmark Russian Federation
Estonia San Marino
Finland Serbia
France Slovakia
Georgia Slovenia
Germany Spain
Greece Sweden
Hungary Switzerland
Iceland Tajikistan
Ireland Turkey
Israel Turkmenistan
Italy Ukraine
Kazakhstan United Kingdom
Kyrgyzstan Uzbekistan
Latvia
WHO/EURO:2021-2741-42499-59030
World Health Organization
Regional Office for Europe
UN City,
Marmorvej 51,
DK-2100 Copenhagen Ø, Denmark
Tel.: +45 45 33 70 00 Fax: +45 45 33 70 01
Email: eurocontact@who.int
Website: www.euro.who.int
52